EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis

Tzu-Fei Wang, Roger Kou, Marc Carrier, Aurélien Delluc

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2023.11.017 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Tzu-Fei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: t…. Hauptthemen laut MEDLINE: Neoplasms, Upper Extremity Deep Vein Thrombosis, Anticoagulants, Hemorrhage. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Servier.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with cancer commonly require a central venous catheter, which is associated with an increased risk of venous thromboembolism (VTE). Despite the frequent occurrence, the optimal anticoagulation management and outcomes for patients with cancer and catheter-related upper extremity deep vein thrombosis (DVT) are unclear. OBJECTIVE: We performed a systematic review and meta-analysis to evaluate the rates of recurrent VTE and bleeding in patients with cancer and catheter-related upper extremity DVT. METHODS: We searched MEDLINE, Embase, Scopus, and CENTRAL from inception to June 2, 2023. The primary efficacy outcome was recurrent VTE, and the primary safety outcome was major bleeding. The incidence rates (with 95% CI) of outcomes were pooled using random effects model. RESULTS: We included 29 studies (N = 2,836), among which 5 were prospective. The duration of follow-up and anticoagulation varied considerably. The main long-term anticoagulant used was low molecular weight heparin, followed by direct oral anticoagulants. The pooled 3-month recurrent VTE rate from 14 studies (N = 1,128) was 0.56% (95% CI, 0.10%-3.01%; I2 = 0%). The pooled 3-month major bleeding rate from 10 studies (N = 834) was 2.34% (95% CI, 1.14%-4.76%; I2 = 0%). We were unable to pool event rates beyond 3 months, given high heterogeneity. All studies had serious risk of bias. CONCLUSIONS: Our study demonstrated a relatively low rate of recurrent VTE and moderate rate of major bleeding events within the first 3 months in patients with cancer and catheter-related upper extremity DVT. However, there was significant heterogeneity in the management and reporting after 3 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsUpper Extremity Deep Vein ThrombosisAnticoagulantsHemorrhageRecurrenceHumansRisk FactorsCentral Venous CathetersTreatment OutcomeFemaleCatheterization, Central VenousMaleMiddle AgedAgedRisk AssessmentVenous Thromboembolism

Stichwörter der Autor:innen

cancer-associated thrombosiscentral venous catheterdeep vein thrombosismalignancymeta-analysissystematic review

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: tzwang@toh.ca.
  • Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: https://twitter.com/MarcCarrier1.
  • Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: https://twitter.com/DellucAurelien.

Förderung

  • Servier

Zitieren

APA

Wang, T. F., Kou, R., Carrier, M., & Delluc, A. (2024). Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.11.017

Vancouver

Wang TF, Kou R, Carrier M, Delluc A. Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2023.11.017

BibTeX
@article{Wang2024,
  author = {Wang, Tzu-Fei and Kou, Roger and Carrier, Marc and Delluc, Aurélien},
  title = {Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2023.11.017}
}
Kostenlos starten →